Filing Details
- Accession Number:
- 0001562180-21-004152
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-09 16:26:29
- Reporting Period:
- 2021-06-07
- Accepted Time:
- 2021-06-09 16:26:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1517022 | Akebia Therapeutics Inc. | AKBA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1379970 | C Steven Gilman | C/O Akebia Therapeutics, Inc. 245 First St. Cambridge MA 02142 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-06-07 | 4,567 | $3.32 | 47,997 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This sale was made pursuant to a 10b5-1 trading plan to cover tax withholding obligations in connection with the vesting and settlement of 100% of the Reporting Person's restricted stock units granted on June 5, 2020.
- This transaction was executed in multiple trades at prices ranging from $3.3201 USD to $3.325 USD; the price reported above reflects the weighted average sale price.